Supplementary Figure 3| Illustration of the kinetics for recognition of thymidylate synthase in cell lysates from K562 cells in the AlphaScreen assay. Four different antibody combinations were selected for testing based on the results of the experiment in Supplementary Fig. 2 . The experiment was performed to address the ability of the four different antibody pairs to recognize thymidylate synthase also in the context of cell lysates. Establishment of an equilibrium signal that remains stable over several hours is essential to allow parallel processing of multiple plates in screening campaigns. For each tested pair the signal to background is given as a function of time after addition of antibodies and beads: 2h (green), 6h (magenta) and 18h (blue). Data are provided as the average and standard error of mean from experiments done in triplicate at one test occasion. Based on the combination of an excellent signal to background and a comparatively fast and stable recognition of thymidylate synthase also in the context of the cell lysates we decided on a pair based on the mouse M3 and the rabbit R2 antibodies (Supplementary Table 1 ) for further assay development purposes.
Supplementary Figure 4| Illustration of the AlphaScreen response for thymidylate synthase as a function of antibody concentrations.
Given that a multi-component complex must be formed to yield a productive assay signal (see Supplementary Fig. 1 for an illustration of the assay principle) the antibody concentrations must be titrated to avoid hook effects in the assay. Data are shown as a 3D contour graph where the concentrations of the antibodies directed towards thymidylate synthase are varied on the x-axis (R2) and y-axis (M3), respectively (see Supplementary Table 1 for details on the antibodies). The experiment was done based on a cell lysate from 7.5 million K562 cells per mL. Data are provided as the average from experiments done with n=2-4 for each condition obtained at one test occasion. Based on these results we decided to use 0.4 nM M3 and 1.0 nM R2 in the final screening assay.
Supplementary Figure 5| Illustration of the AlphaScreen® signal for human thymidylate synthase as a function of K562 cell numbers.
For assays measuring the content of soluble protein it is important to work in a range where the signal responds linearly with the cell numbers. Data are shown as the average and standard error of mean from triplicate samples obtained at one test occasion. Labels are as follows: cell lysate from cells kept at room temperature (green circle) or after heating to 52°C for 3 minutes (magenta square). This transient heat treatment denatures and precipitates thymidylate synthase in these cells (Fig. 1b in main text) . In order to maximize the signal window without the risk of saturating the detection system we decided to use 5 million K562 cells per ml in the final screening assay.
Supplementary Figure 6| Illustration of the change in AlphaScreen® signal as a function of added recombinant thymidylate synthase to K562 cell lysates.
To address the specificity of the selected dual antibody pair (M3 and R2; Supplementary Table 1) for recognition of human thymidylate synthase in the context of a complex cell lysate we performed seeding experiments with thymidylate synthase added to unheated cell lysates (blue triangle), lysates heated to 52°C for 3 minutes (magenta square), or to cell medium without any cells (green circle). The insert illustrates the same data, but restricted to the 0-0.2 nM concentration range. Data are shown from one test occasion as the average and standard error of mean (S.E.M) from triplicate samples. To stay within the linear range of the assay response the cell lysate background corresponded to 1 million K562 cells per ml. Although the background levels in the absence of TS are different for the unheated lysate, reflecting the TS levels in the K562 cells, there is a corresponding increase in the signal in both lysates, whereas the signal increase is somewhat steeper in the absence of the cell lysate background. Based on these data we conclude that the signal scales with thymidylate synthase content also in the cell lysates.
Supplementary Figure 7|
Comparison of Western blot and AlphaScreen based responses for floxuridine and raltitrexed. (a) Western blot data from CETSA experiments performed to determine T agg curves for thymidylate synthase in live cells following a 2h preincubation period in the presence of DMSO (green circle and lavender blue downwards triangle) and 5 µM floxuridine (blue square) or 5 µM raltitrexed (magenta upwards triangle). To the right of the graphs are the corresponding chemiluminescence data. (b) Western blot based ITDRF CETSA following a 2h preincubation period at 37°C at different concentrations of floxuridine (starting at 300 nM and serially diluted in 11 steps down to 5 pM) (blue square) and raltitrexed (starting at 4 µM and serially diluted down to 67 pM) (magenta upwards triangle) and after heating for 3 minutes at 50°C. To the right of the graphs are the corresponding chemiluminescence data probing TS as well as the corresponding β-actin levels. All Western blot experiments were performed on K562 cells at a minimum of two independent biological replicates. (c) Illustration of the AlphaScreen® response in lysates from K562 cells for DMSO (green bars) and floxuridine treated cells (blue bars). Data are shown as the average and S.E.M. for two independent biological replicates following a 2h pre-incubation period. While Western blot experiments demonstrate similar protein levels between controls and treated samples (see panel a), we consistently observed a significant attenuation (∼50%) of the AlphaScreen® signal for fluoropyrimidines. Intracellular enzymatic conversions of the fluoropyrimidines generate the active species FdUMP that forms a ternary covalent complex with thymidylate synthase and 5,10-methylenetetrahydrofolate (see panel a for a characteristic shift in electrophoretic mobility of the ternary complex) 1 . As previously reported 2 , we commonly observe ligand induced attenuation of the AlphaScreen signal® in the no-wash assay setup because the ligand is present also during detection. Despite the observation of signal attenuation for a small number of covalently binding compounds in this case we proceeded with the selected antibody pair and assay setup since it resulted in excellent assay performance. Figure 8| Schematic outline of the small molecule screening logistics applied in the screening campaign on human thymidylate synthase using CETSA. Compounds and controls were dispensed to round-bottomed 384-well plates using an Echo 550 and diluted with supplemented cell medium using a Multidrop Combi. The diluted compounds were next transferred to 384-well PCR plates using a Bravo liquid handling station. K562 suspension cells were then added using a multipipette followed by preincubation for 2h in a cell incubator at 37°C. The PCR plates were next heated transiently to 50°C for three minutes followed by a controlled cooling to 20 o C using a Roche Lightcycler480. The plates were then centrifuged briefly and subsequently cell lysis was accomplished by addition of lysis buffer using a Flexdrop IV. To ensure sufficient lysis the cell lysates were thoroughly mixed by ten repetitions of aspirations and dispenses using the 384-well head of the Bravo. Part of the lysates were then transferred to white 384-well plates followed by the addition of antibodies and AlphaScreen® acceptor and donor beads using a Multidrop Combi under subdued light. The plates were incubated over night at room temperature prior to detection in an Envision plate reader. As described in the Methods section the plates were sealed under several of these steps. Table  3) . A key difference between these experiments was the use of different sources for the compound solutions. Whereas the screen was based on compound solutions plated from Labcyte 384 LDV plates, the hit confirmation experiment was based on compound solutions taken directly from a vial based storage system at CBCS. Additional experiments on these two sets of compound solutions were hence performed to investigate whether the CETSA screen was associated with a poor hit confirmation rate or whether there were different activities observed in the two sets of compound solutions. (a) Correlation between the responses observed in the primary screening campaign (single replicate) and a follow-up experiment based on solutions from the same Labcyte 384 LDV compound source plates (illustrated as the average of a duplicate obtained at one test occasion). Out of 15 tested solutions 12 reproduced significant activity (green circle) with a correlation coefficient of 0.56 between the two experiments, whereas three solutions failed to reproduce activity (magenta square). (b) Comparison of activities observed on solutions taken from the Labcyte 384 LDV compound source plates on the x-axis versus those prepared from the REMP vial storage system on the y-axis (in both cases illustrated as the averages of duplicate measurements obtained at one test occasion). Regardless of whether the hits reproducibly showed activity (green circle), or not (magenta square), when tested from the source plates that were applied in the primary screening campaign they failed to demonstrate activities approaching 30% stabilization when tested based on the REMP vial solutions. The source plates were generated by tip based transfer of solutions from the REMP-based vials to the compound plates using a 96-well head and these solutions were then moved further with a 384-well head into 1536-well plates. In both these transfers the tips were washed extensively with DMSO between vials and plates. Despite these precautions careful inspection of the laboratory notes describing the generation of the Labcyte 384 LDV plates demonstrates that five of the contaminated solutions had been in contact with a pipette tip that had transferred a 10 mM floxuridine solution in a preceding step, while another three repeatedly active solutions were adjacent to wells containing floxuridine. Based on these observations we concluded that the original source plates are cross-contaminated and generated new plates for future screening campaigns. These compounds were identified based on sub-structure searches within the primary screening set of 10,928 compounds. These searches were based on uridine, cytidine and anti-folate like compounds according to the following rules:
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